vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($30.9M vs $23.1M, roughly 1.3× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 5.6%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 2.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

ADCT vs CHCT — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.3× larger
CHCT
$30.9M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+30.7% gap
ADCT
36.4%
5.6%
CHCT
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
2.7%
CHCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
CHCT
CHCT
Revenue
$23.1M
$30.9M
Net Profit
$14.4M
Gross Margin
Operating Margin
-77.7%
Net Margin
46.6%
Revenue YoY
36.4%
5.6%
Net Profit YoY
687.6%
EPS (diluted)
$0.04
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
CHCT
CHCT
Q4 25
$23.1M
$30.9M
Q3 25
$15.8M
$31.1M
Q2 25
$18.1M
$29.1M
Q1 25
$17.4M
$30.1M
Q4 24
$16.9M
$29.3M
Q3 24
$18.0M
$29.6M
Q2 24
$17.0M
$27.5M
Q1 24
$17.8M
$29.3M
Net Profit
ADCT
ADCT
CHCT
CHCT
Q4 25
$14.4M
Q3 25
$-41.0M
$1.6M
Q2 25
$-56.6M
$-12.6M
Q1 25
$-38.6M
$1.6M
Q4 24
$1.8M
Q3 24
$-44.0M
$1.7M
Q2 24
$-36.5M
$-10.4M
Q1 24
$-46.6M
$3.7M
Operating Margin
ADCT
ADCT
CHCT
CHCT
Q4 25
-77.7%
Q3 25
-196.6%
Q2 25
-244.1%
Q1 25
-163.5%
Q4 24
-191.8%
Q3 24
-197.4%
Q2 24
-170.5%
Q1 24
-188.3%
Net Margin
ADCT
ADCT
CHCT
CHCT
Q4 25
46.6%
Q3 25
-260.1%
5.3%
Q2 25
-313.2%
-43.2%
Q1 25
-221.8%
5.3%
Q4 24
6.3%
Q3 24
-244.1%
5.9%
Q2 24
-214.6%
-37.9%
Q1 24
-261.1%
12.5%
EPS (diluted)
ADCT
ADCT
CHCT
CHCT
Q4 25
$0.04
$0.52
Q3 25
$-0.30
$0.03
Q2 25
$-0.50
$-0.50
Q1 25
$-0.36
$0.03
Q4 24
$-0.26
$0.04
Q3 24
$-0.42
$0.04
Q2 24
$-0.38
$-0.42
Q1 24
$-0.56
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$261.3M
$3.3M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$-185.8M
$429.4M
Total Assets
$323.1M
$990.8M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
CHCT
CHCT
Q4 25
$261.3M
$3.3M
Q3 25
$234.7M
$3.4M
Q2 25
$264.6M
$4.9M
Q1 25
$194.7M
$2.3M
Q4 24
$250.9M
$4.4M
Q3 24
$274.3M
$2.8M
Q2 24
$300.1M
$734.0K
Q1 24
$234.3M
$3.8M
Total Debt
ADCT
ADCT
CHCT
CHCT
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
ADCT
ADCT
CHCT
CHCT
Q4 25
$-185.8M
$429.4M
Q3 25
$-238.2M
$426.8M
Q2 25
$-199.2M
$437.8M
Q1 25
$-238.2M
$461.3M
Q4 24
$-202.6M
$476.0M
Q3 24
$-171.9M
$477.2M
Q2 24
$-131.7M
$497.8M
Q1 24
$-194.4M
$511.6M
Total Assets
ADCT
ADCT
CHCT
CHCT
Q4 25
$323.1M
$990.8M
Q3 25
$289.8M
$987.3M
Q2 25
$321.6M
$966.3M
Q1 25
$272.5M
$985.1M
Q4 24
$322.0M
$992.6M
Q3 24
$349.1M
$981.8M
Q2 24
$371.8M
$983.2M
Q1 24
$308.0M
$982.7M
Debt / Equity
ADCT
ADCT
CHCT
CHCT
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
CHCT
CHCT
Operating Cash FlowLast quarter
$-31.1M
$56.4M
Free Cash FlowOCF − Capex
$35.9M
FCF MarginFCF / Revenue
116.0%
Capex IntensityCapex / Revenue
0.0%
66.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
CHCT
CHCT
Q4 25
$-31.1M
$56.4M
Q3 25
$-29.6M
$12.7M
Q2 25
$-24.1M
$13.8M
Q1 25
$-56.3M
$14.4M
Q4 24
$-21.9M
$58.9M
Q3 24
$-25.0M
$13.8M
Q2 24
$-32.8M
$16.7M
Q1 24
$-44.1M
$12.6M
Free Cash Flow
ADCT
ADCT
CHCT
CHCT
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$-56.6M
$9.7M
Q4 24
$-21.9M
$34.2M
Q3 24
$-25.3M
$6.7M
Q2 24
$-32.9M
$9.5M
Q1 24
$-44.6M
$7.5M
FCF Margin
ADCT
ADCT
CHCT
CHCT
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
-325.2%
32.3%
Q4 24
-129.8%
116.9%
Q3 24
-140.2%
22.5%
Q2 24
-193.0%
34.7%
Q1 24
-250.0%
25.7%
Capex Intensity
ADCT
ADCT
CHCT
CHCT
Q4 25
0.0%
66.3%
Q3 25
0.0%
16.3%
Q2 25
0.0%
14.5%
Q1 25
1.5%
15.6%
Q4 24
0.5%
84.1%
Q3 24
1.2%
24.2%
Q2 24
0.2%
26.1%
Q1 24
3.0%
17.4%
Cash Conversion
ADCT
ADCT
CHCT
CHCT
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons